Atlas Trials

S-INFINITY Pharmaceuticals Co., Ltd

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch S-INFINITY Pharmaceuticals Co., Ltd

RecordFirmDate
A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT07657052)S-INFINITY Pharmaceuticals Co., Ltd2025-08-15
The Phase Ib Clinical Trial of the XH-S004 Tablet in Patients With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate Its Safety, Tolerability, Pharmacokinetic Characteristics and Pharmacodynamic Characteristics After Multiple Administrations (NCT07035652)S-INFINITY Pharmaceuticals Co., Ltd2025-07-15
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis (NCT06981091)S-INFINITY Pharmaceuticals Co., Ltd2025-05-16
A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT06978699)S-INFINITY Pharmaceuticals Co., Ltd2025-04-30
A Phase IIa Study in Primary IgA Nephropathy Patients (NCT07634744)S-INFINITY Pharmaceuticals Co., Ltd2024-12-31
A Phase I Study of XH-S004 in Healthy Volunteers (NCT06236841)S-INFINITY Pharmaceuticals Co., Ltd2024-01-26
A Phase I Study of XH-S002 in Healthy Volunteers (NCT06204419)S-INFINITY Pharmaceuticals Co., Ltd2023-12-26
A Phase 1 Study of XH-S003 in Healthy Volunteers (NCT05946876)S-INFINITY Pharmaceuticals Co., Ltd2023-08-24
Study of XH-S003 in Healthy Volunteers (NCT06272747)S-INFINITY Pharmaceuticals Co., Ltd2023-07-10

Track S-INFINITY Pharmaceuticals Co., Ltd automatically

Every clearance here is in the API, with alerts when new ones post.